High bone turnover in Muslim women with vitamin D deficiency

2002 ◽  
Vol 177 (3) ◽  
pp. 139-141 ◽  
Author(s):  
Terrence H Diamond ◽  
Sherel Levy ◽  
Angelina Smith ◽  
Peter Day
Keyword(s):  
Vitamin D ◽  
Bone Turnover ◽  
Vitamin D Deficiency ◽  
Muslim Women ◽  
High Bone Turnover ◽  
High Bone

scholarly journals High bone turnover in critically vitamin-D-deficient patients

Critical Care ◽  
2011 ◽  
Vol 15 (S1) ◽  
Author(s):  
K Amrein ◽  
H Sourij ◽  
A Holl ◽  
C Schnedl ◽  
TR Pieber ◽  
...  
Keyword(s):  
Vitamin D ◽  
Bone Turnover ◽  
High Bone Turnover ◽  
High Bone

E85 Idiopathic relapsing lithiasis with hypercalciuria is accompanied by high bone turnover and low vitamin D levels

2013 ◽  
Vol 12 (3) ◽  
pp. 59
Author(s):  
C. Pricop ◽  
D. Branisteanu ◽  
D.N. Serban ◽  
D. Ungureanu ◽  
I.L. Serban
Keyword(s):  
Vitamin D ◽  
Bone Turnover ◽  
High Bone Turnover ◽  
Vitamin D Levels ◽  
High Bone

scholarly journals Low Vitamin D Status, High Bone Turnover, and Bone Fractures in Centenarians

2003 ◽  
Vol 88 (11) ◽  
pp. 5109-5115 ◽  
Author(s):  
Giovanni Passeri ◽  
Gabriella Pini ◽  
Leonarda Troiano ◽  
Rosanna Vescovini ◽  
Paolo Sansoni ◽  
...  
Keyword(s):  
Vitamin D ◽  
Bone Turnover ◽  
Bone Fractures ◽  
Vitamin D Status ◽  
High Bone Turnover ◽  
High Bone

High bone turnover persisting after vitamin D repletion: beware of calcium deficiency

2013 ◽  
Vol 24 (8) ◽  
pp. 2359-2363 ◽  
Author(s):  
M.-H. Lafage-Proust ◽  
L. Lieben ◽  
G. Carmeliet ◽  
C. Soler ◽  
C. Cusset ◽  
...  
Keyword(s):  
Vitamin D ◽  
Bone Turnover ◽  
Calcium Deficiency ◽  
High Bone Turnover ◽  
High Bone

Vitamin D Deficiency and Intoxication - A concern either way

JMS SKIMS ◽  
2011 ◽  
Vol 14 (2) ◽  
pp. 40-42
Author(s):  
Muzafar Maqsood Wani ◽  
Imtiaz Ahmed Wani
Keyword(s):  
Vitamin D ◽  
Cell Growth ◽  
Bone Turnover ◽  
Secondary Hyperparathyroidism ◽  
Vitamin D Deficiency ◽  
Bone Mineralization ◽  
Normal Blood ◽  
Blood Levels ◽  
Calcium And Phosphorus ◽  
Biologic Function

Major biologic function of activated vitamin D is to maintain normal blood levels of calcium and phosphorus, thus regulating bone mineralization. Research suggests that vitamin D may help in immunomodulation, regulating cell growth and 1,4 differentiation as well as some diverse unspecified functions. Overt vitamin D deficiency leads to hypocalcaemia, secondary hyperparathyroidism and increased bone turnover, which in prolonged and severe cases may cause rickets in children and osteomalacia in elderly.... JMS 2011;14(2):40-42

scholarly journals The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves’ Disease

PLoS ONE ◽  
2015 ◽  
Vol 10 (12) ◽  
pp. e0144599 ◽  
Author(s):  
Sun Wook Cho ◽  
Jae Hyun Bae ◽  
Gyeong Woon Noh ◽  
Ye An Kim ◽  
Min Kyong Moon ◽  
...  
Keyword(s):  
Bone Turnover ◽  
Graves Disease ◽  
Blocking Antibody ◽  
High Bone Turnover ◽  
High Bone ◽  
Premenopausal Patients

scholarly journals No association between vitamin D deficiency and parathyroid hormone, bone density and bone turnover in a large cohort of HIV-infected men on tenofovir

2014 ◽  
Vol 17 ◽  
pp. 19568 ◽  
Author(s):  
Amanda Samarawickrama ◽  
Sophie Jose ◽  
Caroline Sabin ◽  
Karen Walker-Bone ◽  
Martin Fisher ◽  
...  
Keyword(s):  
Vitamin D ◽  
Parathyroid Hormone ◽  
Bone Density ◽  
Bone Turnover ◽  
Vitamin D Deficiency ◽  
Large Cohort

scholarly journals Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation

2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Elena Gonzalez-Rodriguez ◽  
Delphine Stoll ◽  
Olivier Lamy
Keyword(s):  
Bone Loss ◽  
Bone Turnover ◽  
Aromatase Inhibitors ◽  
Vertebral Fractures ◽  
Bone Markers ◽  
Rebound Effect ◽  
High Bone Turnover ◽  
Antiresorptive Agent ◽  
High Bone

At denosumab discontinuation, an antiresorptive agent is prescribed to reduce the high bone turnover, the rapid bone loss, and the risk of spontaneous vertebral fractures. We report the case of a woman treated with aromatase inhibitors and denosumab for 5 years. Raloxifene was then prescribed to prevent the rebound effect. Raloxifene was ineffective to reduce the high bone turnover and to avoid spontaneous clinical vertebral fractures. We believe that among the antiresorptive treatments, the most powerful bisphosphonates should be favored, and their administration adapted according to the serial follow-up of bone markers.

Sign in / Sign up

Export Citation Format

Share Document